The Effect Of Statin And Colchicine On Pericoronary Adipose Tissue Inflammation And Coronary Artery Plaque Progression: Insights From Cardiac Computed Tomography Using Pericoronary Adipose Tissue Attenuation And Radiomics
Funder
National Health and Medical Research Council
Funding Amount
$125,396.00
Summary
Coronary artery disease is the leading cause of death in Australia. Inflammation is a key driver of harmful build-up of cholesterol plaques in arteries. Currently it is unclear how to detect patients with high level of inflammation. We examine a new approach to detect coronary inflammation using CT coronary angiography (CTCA). We investigate how to utilise CTCA to guide targeted therapy with statin and colchicine in patients with residual inflammation to reduce risk of future heart attack.
Systemic lupus erythematosus (SLE) is a condition which causes inflammation in many different organs and can lead to significant suffering and death. Glucocorticoids (GC) are very good at controlling inflammation, however they have severe side effects such as diabetes and bone thinning, and cannot be used long term. This project aims to investigate a protein “GILZ” in patients with SLE. GILZ may have similar anti-inflammatory effects to GC but may not be associated with the same side effects.
GENETIC AND FUNCTIONAL CHARACTERISATION OF ERAP1 VARIANTS ASSOCIATED WITH ANKYLOSING SPONDYLITIS.
Funder
National Health and Medical Research Council
Funding Amount
$133,351.00
Summary
Ankylosing Spondylitis is a progressive arthritis which affects the back and causes the back joints to fuse. The project seeks to investigate the role of the ERAP1 protein and the gene which is the blueprint for the ERAP1 protein in causing Ankylosing Spondylitis. This will be through resequencing the gene, investigating the action of the different ERAP1 proteins and the effect of ERAP1 deficiency in mice.
A Comparison Of Arthroscopic Synovial Biopsy Based Targeted Biologic Therapy Versus Conventional Therapy In Rheumatoid Arthritis
Funder
National Health and Medical Research Council
Funding Amount
$133,351.00
Summary
This proposed study will investigate if treatment of rheumatoid arthritis (RA) based on biopsy of affected joints’ lining is better than standard therapy (not based on the results of biopsy). Current strategies to treat RA not infrequently result in incomplete disease suppression with potentially resultant joint damage, in part because of lack of definite guidelines to individualise treatment. We propose that therapy on the basis of the analysis of biopsy of joint lining will lead to better dise ....This proposed study will investigate if treatment of rheumatoid arthritis (RA) based on biopsy of affected joints’ lining is better than standard therapy (not based on the results of biopsy). Current strategies to treat RA not infrequently result in incomplete disease suppression with potentially resultant joint damage, in part because of lack of definite guidelines to individualise treatment. We propose that therapy on the basis of the analysis of biopsy of joint lining will lead to better disease control than the currently prevalent approach.Read moreRead less
Determinants And Impact Of Patient-Centred Health Outcomes In Psoriatic Arthritis
Funder
National Health and Medical Research Council
Funding Amount
$84,069.00
Summary
Psoriatic arthritis is a chronic joint disease which is linked with the skin condition called psoriasis. People who have psoriatic arthritis can develop deformities in their joints and suffer from decreased quality of life. Psoriatic arthritis can present in a wide range of ways, but the reasons for this are not understood. This research aims to explain some of this variation and to predict which patients will develop more severe disease so treatment can be targeted to improve their outcome.
Inflammatory skin disorders, such as psoriasis and dermatitis, are responsible for a large burden of human disease and affect people across alldemographics. Knockout (KO) of TNF signalling members in mice is known to induce skin inflammation. This project proposes to use these genetic mouse models to investigate how and why disruption of particular TNF superfamily members leads to disease and potentially identify new targets for treatment.
Integrated Clinical And Scientific Studies In Post-Operative Crohn’s Disease
Funder
National Health and Medical Research Council
Funding Amount
$71,606.00
Summary
Crohn’s disease is a chronic inflammatory bowel condition; the incidence in Australia is now amongst the highest in the world. Most patients require repeated invasive bowel surgeries when disease recurs. Using data from a past clinical trial comparing preventive treatments for recurrence; genetic, immunological and microbiological testing will be done on existing patient samples. This extensive data set will be analysed using systems biology methods to identify the cause of Crohn’s disease.
Citrullination In Rheumatic And Non-rheumatic Diseases
Funder
National Health and Medical Research Council
Funding Amount
$89,699.00
Summary
Rheumatoid arthritis is a common condition affecting about 1% of the population, leading to damage of joints and subsequently impaired function. This damage is caused by an immune system which rather than defending the host against threats such as infections, inadvertently attacks the host leading to joint damage. Ultimately a better understanding of the abnormal immune responses in patients with RA will allow us to more accurately the diagnose and manage this condition
REMEDYING THE NEGLECT OF THE MOST COMMON COMPLICATION OF INFLAMMATORY BOWEL DISEASE: INTESTINAL STRICTURES.
Funder
National Health and Medical Research Council
Funding Amount
$123,368.00
Summary
Inflammatory bowel disease is a significant cause of debility in the Australian community. Some patients develop narrowing of the bowel which can cause intestinal blockages and require surgery. My research in this area will identify predictors of severe disease, allowing doctors to individualise treatment plans for each patient. I will also work to determine the best model of medical treatment and investigate new techniques which have the potential to avoid surgery.
HMGB1: A Novel Player In The Pathogenesis Of Inflammatory Myositis?
Funder
National Health and Medical Research Council
Funding Amount
$84,800.00
Summary
The project aims to determine whether HMGB1, a pro-inflammatory molecule, plays a key role in the cause of inflammatory myositis, an extremely disabling muscle condition characterised by progressive weakness.